<DOC>
	<DOCNO>NCT00891371</DOCNO>
	<brief_summary>The purpose study , assess effect lanreotide Autogel 120mg stool frequency subject refractory diarrhea day 28 ( mean last 7 day ) compare baseline .</brief_summary>
	<brief_title>Lanreotide Autogel Symptomatic Treatment Refractory Diarrhea</brief_title>
	<detailed_description />
	<mesh_term>Diarrhea</mesh_term>
	<mesh_term>Lanreotide</mesh_term>
	<mesh_term>Angiopeptin</mesh_term>
	<mesh_term>Somatostatin</mesh_term>
	<criteria>Male/female refractory diarrhea least 1 month , normal extend workup exclude cause diarrhea , enough respond standard antidiuretic evaluate investigator Patient mentally fit complete diary Has already receive treatment somatostatin analogue treatment refractory diarrhea Had weight stool &lt; 600g 72hrs stool collection Has receive treatment laxative within last week study entry Suffers IBS alternate bowel habit predominant constipation , suffers infectious and/or inflammatory gastroenteritis ( colitis ulcerosa , crohn 's disease macroscopic colitis )</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2015</verification_date>
	<keyword>symptomatic treatment patient refractory diarrhea</keyword>
</DOC>